Bogart Wealth LLC’s 60 Degrees Pharmaceuticals SXTP Stock Holding History

Bogart Wealth LLC’s Portfolio SXTP Stock Details SXTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-35	Closed	-$903	–	1508
2024 Q4	$903	Buy	+35	New	+$772	﹤0.01%	1217

Other funds holding SXTP

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

SHF

Safe Harbor Fiduciary Pensacola, Florida $105M AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bogart Wealth LLC's SXTP Position: Q1 2025 in Review

Bogart Wealth LLC sold out of 60 Degrees Pharmaceuticals (SXTP) in Q1 2025, closing a stake of 35 shares — an estimated $903 sold.

Bogart Wealth LLC first reported a position in SXTP in Q4 2024 and held it in 1 quarter. The position peaked at $903 in Q4 2024. 6 funds tracked by Wall St. Rank hold SXTP as of Q1 2025.

Bogart Wealth LLC reported no remaining 60 Degrees Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Bogart Wealth LLC sold 35 60 Degrees Pharmaceuticals shares in Q1 2025, an estimated $903.
Bogart Wealth LLC first reported a position in 60 Degrees Pharmaceuticals in Q4 2024 and held it in 1 quarter.
Bogart Wealth LLC's 60 Degrees Pharmaceuticals position peaked at $903 in Q4 2024.
6 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals as of Q1 2025.

Based on Bogart Wealth LLC's 13F filing for Q1 2025, filed 2 May 2025.